Wayde D. McMillan's Insider Trades & SAST Disclosures
Wayde D. McMillan's most recent trade in Solventum Corp was a trade of 26,407 Restricted Stock Units done . Disclosure was reported to the exchange on March 6, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Wayde D. McMillan.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Solventum Corp | Wayde D. McMillan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2025 | 26,407 | 26,407 | - | - | Restricted Stock Units | |
| Solventum Corp | Wayde D. McMillan | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2024 | 28,010 | 28,010 | - | - | Restricted Stock Units | |
| Solventum Corp | Wayde D. McMillan | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2024 | 28,010 | 28,015 | - | 0 | Common Stock | |
| Solventum Corp | Wayde D. McMillan | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.51 per share. | 01 Dec 2024 | 11,112 | 16,903 | - | 71.5 | 794,619 | Common Stock |
| Solventum Corp | Wayde D. McMillan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 28,509 | 28,509 | - | - | Restricted Stock Units | |
| Insulet Corporation | Wayde D. McMillan | EVP, CFO | Sale of securities on an exchange or to another person at price $ 282.94 per share. | 03 Jul 2023 | 1,388 | 21,477 (0%) | 0% | 282.9 | 392,721 | Common Stock |
| Insulet Corporation | Wayde D. McMillan | EVP, CFO | Sale of securities on an exchange or to another person at price $ 318.31 per share. | 03 Apr 2023 | 1,255 | 22,865 (0%) | 0% | 318.3 | 399,479 | Common Stock |
| Insulet Corporation | Wayde D. McMillan | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 6,503 | 6,503 | - | - | Employee Stock Option (Right to Buy) | |
| Insulet Corporation | Wayde D. McMillan | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2023 | 2,713 | 24,120 (0%) | 0% | 0 | Common Stock | |
| Insulet Corporation | Wayde D. McMillan | EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 276.36 per share. | 28 Feb 2023 | 350 | 21,407 (0%) | 0% | 276.4 | 96,726 | Common Stock |
| Insulet Corporation | Wayde D. McMillan | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 3,212 | 22,849 (0%) | 0% | 0 | Common Stock | |
| Insulet Corporation | Wayde D. McMillan | EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 296.00 per share. | 17 Feb 2023 | 1,092 | 21,757 (0%) | 0% | 296 | 323,232 | Common Stock |
| Insulet Corporation | Wayde D. McMillan | EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 296.00 per share. | 17 Feb 2023 | 153 | 19,637 (0%) | 0% | 296 | 45,288 | Common Stock |
| Insulet Corporation | Wayde D. McMillan | EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 294.83 per share. | 10 Feb 2023 | 205 | 19,790 (0%) | 0% | 294.8 | 60,440 | Common Stock |
| Insulet Corporation | Wayde D. McMillan | EVP, CFO | Sale of securities on an exchange or to another person at price $ 286.43 per share. | 03 Jan 2023 | 1,359 | 19,995 (0%) | 0% | 286.4 | 389,258 | Common Stock |
| Insulet Corporation | Wayde D. McMillan | EVP, CFO | Sale of securities on an exchange or to another person at price $ 275.60 per share. | 01 Apr 2022 | 1,455 | 21,354 (0%) | 0% | 275.6 | 400,998 | Common Stock |
| Insulet Corporation | Wayde D. McMillan | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 6,500 | 6,500 | - | - | Employee Stock Option (Right to Buy) | |
| Insulet Corporation | Wayde D. McMillan | EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 260.84 per share. | 28 Feb 2022 | 3,134 | 22,809 (0%) | 0% | 260.8 | 817,473 | Common Stock |
| Insulet Corporation | Wayde D. McMillan | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 2,361 | 25,943 (0%) | 0% | 0 | Common Stock | |
| Insulet Corporation | Wayde D. McMillan | EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 262.37 per share. | 26 Feb 2022 | 522 | 23,582 (0%) | 0% | 262.4 | 136,957 | Common Stock |
| Insulet Corporation | Wayde D. McMillan | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 7,057 | 26,777 (0%) | 0% | 0 | Common Stock | |
| Insulet Corporation | Wayde D. McMillan | EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 234.18 per share. | 18 Feb 2022 | 2,673 | 24,104 (0%) | 0% | 234.2 | 625,963 | Common Stock |
| Insulet Corporation | Wayde D. McMillan | EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 240.81 per share. | 17 Feb 2022 | 153 | 19,720 (0%) | 0% | 240.8 | 36,844 | Common Stock |
| Insulet Corporation | Wayde D. McMillan | EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 252.81 per share. | 10 Feb 2022 | 205 | 19,873 (0%) | 0% | 252.8 | 51,826 | Common Stock |
| Insulet Corporation | Wayde D. McMillan | EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 270.26 per share. | 26 Feb 2021 | 2,847 | 21,933 (0%) | 0% | 270.3 | 769,430 | Common Stock |
| Insulet Corporation | Wayde D. McMillan | EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 259.10 per share. | 26 Feb 2021 | 346 | 24,780 (0%) | 0% | 259.1 | 89,649 | Common Stock |
| Insulet Corporation | Wayde D. McMillan | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 4,553 | 4,553 | - | - | Employee Stock Option (Right to Buy) | |
| Insulet Corporation | Wayde D. McMillan | EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 1,564 | 25,126 (0%) | 0% | 0 | Common Stock | |
| Insulet Corporation | Wayde D. McMillan | EVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 280.15 per share. | 10 Feb 2021 | 202 | 23,562 (0%) | 0% | 280.1 | 56,590 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges